• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于治疗对传统疗法难治的恶性肿瘤的免疫疗法的开发。

Development of immunotherapy for the treatment of malignancies refractory to conventional therapies.

作者信息

Kim S, Haas G P, Hillman G G

机构信息

Department of Urology, Wayne State University School of Medicine, Detroit, MI 48201, USA.

出版信息

Cytokines Mol Ther. 1996 Mar;2(1):13-9.

PMID:9384685
Abstract

The key to understanding cancer has eluded scientists for years. As we discover new and more effective approaches to the treatment of cancer, the more we have yet to explore. Despite landmark advances in molecular biology and surgical adjuvant therapy in the past decade, cancer remains a significant life threat. Most metastatic cancers are refractory to conventional therapies, including surgery, radiation therapy and chemotherapy. Therefore constant efforts are being made to develop more effective treatment modalities. Immunotherapy, which is based on the enhancement of an immune response against the host tumor, has been particularly promising. In this review, we shall address the origins, development and future directions of immunotherapy.

摘要

多年来,理解癌症的关键一直让科学家们捉摸不透。随着我们发现越来越多治疗癌症的新方法且这些方法愈发有效,我们有待探索的领域也越来越多。尽管在过去十年分子生物学和手术辅助治疗取得了具有里程碑意义的进展,但癌症仍然严重威胁着生命。大多数转移性癌症对包括手术、放疗和化疗在内的传统疗法具有抗性。因此,人们一直在不断努力开发更有效的治疗方式。基于增强针对宿主肿瘤的免疫反应的免疫疗法一直特别有前景。在这篇综述中,我们将探讨免疫疗法的起源、发展和未来方向。

相似文献

1
Development of immunotherapy for the treatment of malignancies refractory to conventional therapies.用于治疗对传统疗法难治的恶性肿瘤的免疫疗法的开发。
Cytokines Mol Ther. 1996 Mar;2(1):13-9.
2
Adoptive cellular therapy.过继性细胞疗法
Semin Oncol. 2000 Apr;27(2):221-33.
3
[Interleukin-2 and adoptive immunotherapy: their biological aspects and clinical application in oncology].[白细胞介素-2与过继性免疫疗法:其生物学特性及在肿瘤学中的临床应用]
Rev Clin Esp. 1991 May;188(9):468-72.
4
[A new therapeutic concept in the treatment of metastatic cancers of the kidney: the TIL (tumor infiltrating lymphocytes)].[治疗肾转移性癌的一种新治疗理念:肿瘤浸润淋巴细胞(TIL)]
J Urol (Paris). 1991;97(2):63-71.
5
On the road to a tumor cell vaccine: 20 years of cellular immunotherapy.通往肿瘤细胞疫苗之路:20年的细胞免疫疗法。
Vaccine. 2004 Nov 15;23(1):97-113. doi: 10.1016/j.vaccine.2003.12.036.
6
Therapy with interleukin-2 and tumor-derived activated lymphocytes.白细胞介素-2与肿瘤来源的活化淋巴细胞治疗。
Immunol Ser. 1994;61:251-71.
7
Immunotherapy and gene therapy of cancer.癌症的免疫疗法和基因疗法。
Cancer Res. 1991 Sep 15;51(18 Suppl):5074s-5079s.
8
T cell-based immunotherapy of metastatic renal cell carcinoma: modest success and future perspective.基于T细胞的转移性肾细胞癌免疫疗法:取得一定成功及未来展望
Clin Cancer Res. 2009 Nov 1;15(21):6503-10. doi: 10.1158/1078-0432.CCR-09-1605. Epub 2009 Oct 20.
9
[Cancer immunotherapy: immunologic bases, reality and hopes].[癌症免疫疗法:免疫学基础、现状与展望]
Bull Cancer. 1993 Jul;80(7):584-600.
10
Immunotherapy and gene therapy of thyroid cancer.甲状腺癌的免疫治疗与基因治疗
Minerva Endocrinol. 2004 Dec;29(4):175-87.

引用本文的文献

1
Specific immunotherapy of cancer in elderly patients.老年患者癌症的特异性免疫疗法。
Drugs Aging. 2001;18(9):639-64. doi: 10.2165/00002512-200118090-00002.
2
Role of prolactin in the in vitro development of interleukin-2-driven anti-tumoural lymphokine-activated killer cells.催乳素在白细胞介素-2驱动的抗肿瘤淋巴因子激活的杀伤细胞体外发育中的作用。
Immunology. 1996 Dec;89(4):619-26. doi: 10.1046/j.1365-2567.1996.d01-773.x.